Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-d-Aspartate Receptor

Patients with systemic lupus erythematosus (SLE) experience cognitive abnormalities in multiple domains including processing speed, executive function, and memory. Here we show that SLE patients carrying antibodies that bind DNA and the GluN2A and GluN2B subunits of the N-methyl-d-aspartate receptor...

Full description

Saved in:
Bibliographic Details
Published in:EBioMedicine 2015-07, Vol.2 (7), p.755-764
Main Authors: Chang, Eric H., Volpe, Bruce T., Mackay, Meggan, Aranow, Cynthia, Watson, Philip, Kowal, Czeslawa, Storbeck, Justin, Mattis, Paul, Berlin, RoseAnn, Chen, Huiyi, Mader, Simone, Huerta, Tomás S., Huerta, Patricio T., Diamond, Betty
Format: Article
Language:English
Subjects:
Adult
Animals
Antibodies, Antinuclear - immunology
Autoantibodies - metabolism
CA1 place cell
Cell Membrane - metabolism
Cognition
Dendrites - metabolism
Female
HEK293 Cells
Hippocampus
Hippocampus - pathology
Humans
Lupus
Lupus Erythematosus, Systemic - immunology
Male
Mice, Inbred BALB C
Middle Aged
Mouse lupus model
Neuropsychiatric lupus
Original
Pyramidal Cells - metabolism
Receptors, N-Methyl-D-Aspartate - immunology
Space Perception
Spatial Memory
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with systemic lupus erythematosus (SLE) experience cognitive abnormalities in multiple domains including processing speed, executive function, and memory. Here we show that SLE patients carrying antibodies that bind DNA and the GluN2A and GluN2B subunits of the N-methyl-d-aspartate receptor (NMDAR), termed DNRAbs, displayed a selective impairment in spatial recall. Neural recordings in a mouse model of SLE, in which circulating DNRAbs penetrate the hippocampus, revealed that CA1 place cells exhibited a significant expansion in place field size. Structural analysis showed that hippocampal pyramidal cells had substantial reductions in their dendritic processes and spines. Strikingly, these abnormalities became evident at a time when DNRAbs were no longer detectable in the hippocampus. These results suggest that antibody-mediated neurocognitive impairments may be highly specific, and that spatial cognition may be particularly vulnerable to DNRAb-mediated structural and functional injury to hippocampal cells that evolves after the triggering insult is no longer present. •Lupus patients with NMDAR-reactive antibodies (DNRAbs) show impaired spatial memory.•Mice in which DNRAbs penetrate the hippocampus have defective CA1 place cells.•CA1 and CA3 pyramidal cells exposed to DNRAbs display reduced dendritic processes.•DNRAb exposure initiates a progressive compromise in pyramidal neurons.•Lupus antibody effects evolve even after DNRAbs are no longer present in the brain.
ISSN:2352-3964
2352-3964
DOI:10.1016/j.ebiom.2015.05.027